FlightBridgeED
Vasopressin 

Vasopressin - AVERT Trial Results... Wow!

Throughout the course of modern medicine, old methods fall as new ones emerge safer, more reliable, better for patient outcomes, and more. Sims et al., Says this: "Resuscitation strategies that decrease the need for transfusions without increasing complications, therefore, would represent a clinically important innovation".  Research is deep and results are shared throughout the world. One of the fastest-growing, most industry-related sections of medicine today is that of resuscitation. In this episode of The FlightBridgeED Podcast, Eric presents the newly published research just released on the AVERT Trial.  Remember we introduced this abstract in a podcast called "Vasopressin The Master Medication - September 17, 2017.  Well... the evidence is out!  This is groundbreaking stuff in trauma resuscitation, don't miss it!  Don’t forget to rate and especially review wherever you got your podcasts. These reviews are especially key to keeping us high on the charts where your friends and colleagues can find us. Thank you for listening.


SubscribeOn iTunes SubscribeOn Android
DownloadAs MP3 ListenerSurvey

Show Notes

 AVERT: Arginine Vasopressin on Need for Blood Product Transfusions in Patients With Trauma and Hemorrhagic Shock

By accepting you will be accessing a service provided by a third-party external to https://flightbridgeed.com/

Please publish modules in offcanvas position.

FlightBridgeED Logo

One acccount to unlock a universe of discovery

FlightBridgeED® FAST Symposium™ EMerge™

Don't have an account yet? Register Now!

Sign in to your account